Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navitoclax + Rituximab in CLL
NCT01087151Phase 2Completed
- Sponsor
- Genentech
- Start
- Aug 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of navitoclax in chronic lymphocytic leukemia (CLL), sponsored by Genentech. Started Aug 2010; status: completed.
02
Drugs
navitoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01087151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087151.